Oruka Therapeutics, Inc.·4

Jul 1, 9:26 PM ET

Sandler Laura Lee 4

4 · Oruka Therapeutics, Inc. · Filed Jul 1, 2025

Insider Transaction Report

Form 4
Period: 2025-07-01
Sandler Laura Lee
Chief Operating Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-07-01+25,00025,000 total
    Exercise: $11.80Exp: 2035-06-30Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 1/4 of the underlying shares on July 1, 2026, and as to 1/48 of the underlying shares monthly thereafter.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES